Serum Vascular Endothelial Growth Factor Receptor-3 Levels in Patients With Esophageal Squamous Cell Cancer
| dc.authorid | Kemik, Ozgur/0000-0002-4612-1428 | |
| dc.authorid | Demir, Ali/0000-0002-9794-1768 | |
| dc.authorscopusid | 26653741600 | |
| dc.authorscopusid | 57194020007 | |
| dc.authorscopusid | 35332340400 | |
| dc.authorscopusid | 55682194900 | |
| dc.authorscopusid | 37071316400 | |
| dc.authorscopusid | 57194026798 | |
| dc.authorscopusid | 6504310163 | |
| dc.authorwosid | Yavuz, Alpaslan/H-3947-2014 | |
| dc.authorwosid | Kemik, Ozgur/Mgb-2153-2025 | |
| dc.authorwosid | Sümer, Aziz/Ahh-3357-2022 | |
| dc.contributor.author | Sumer, Aziz | |
| dc.contributor.author | Demir, Ali | |
| dc.contributor.author | Kemik, Ahu Sarbay | |
| dc.contributor.author | Yavuz, Alpaslan | |
| dc.contributor.author | Suvak, Burak | |
| dc.contributor.author | Dulger, Ahmet Cumhur | |
| dc.contributor.author | Kemik, Ozgur | |
| dc.date.accessioned | 2025-05-10T17:49:17Z | |
| dc.date.available | 2025-05-10T17:49:17Z | |
| dc.date.issued | 2017 | |
| dc.department | T.C. Van Yüzüncü Yıl Üniversitesi | en_US |
| dc.department-temp | [Sumer, Aziz; Demir, Ali; Kemik, Ozgur] Yuzuncu Yil Univ Med Fac, Dept Gen Surg, Van, Turkey; [Kemik, Ahu Sarbay] Istanbul Univ, Fac Med, Dept Biochem, Istanbul, Turkey; [Yavuz, Alpaslan] Yuzuncu Yil Univ Med Fac, Dept Radiol, Van, Turkey; [Suvak, Burak; Dulger, Ahmet Cumhur] Yuzuncu Yil Univ Med Fac, Dept Gastroenterol, Van, Turkey; [Purisa, Sevim] Istanbul Univ, Fac Med, Dept Biostat, Istanbul, Turkey | en_US |
| dc.description | Kemik, Ozgur/0000-0002-4612-1428; Demir, Ali/0000-0002-9794-1768 | en_US |
| dc.description.abstract | AIM: Esophageal cancer is one of the most aggressive tumors of the gastrointestinal tract. In this study, we quantified the serum vascular endothelial growth factor-3 (VEGFR-3) expression in patients with esophageal squamous cell carcinoma (ESCC) to evaluate the role of VEGFR-3 in ESCC. MATERIALS AND METHODS: Ninety five patients with ESCC were studied. Pre-therapy and preoperative samples were stored and ELISA was used to designate the concentrations of VEGFR-3. RESULTS: The serum values of VEGFR-3 were significantly higher in patients with ESCC than in healthy donors (p<0.0001). CONCLUSIONS: The results imply a very good sensitivity of VEGFR-3 in ESCC. VEGFR-3 may be a good diagnostic biomarker for ESCC. | en_US |
| dc.description.woscitationindex | Science Citation Index Expanded | |
| dc.identifier.endpage | 25 | en_US |
| dc.identifier.issn | 0003-469X | |
| dc.identifier.issn | 2239-253X | |
| dc.identifier.issue | 1 | en_US |
| dc.identifier.pmid | 28447586 | |
| dc.identifier.scopus | 2-s2.0-85018273499 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 20 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.14720/17413 | |
| dc.identifier.volume | 88 | en_US |
| dc.identifier.wos | WOS:000398426800004 | |
| dc.identifier.wosquality | Q4 | |
| dc.language.iso | en | en_US |
| dc.publisher | Edizioni Luigi Pozzi | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Biomarker | en_US |
| dc.subject | Escc | en_US |
| dc.subject | Vegfr-3 | en_US |
| dc.title | Serum Vascular Endothelial Growth Factor Receptor-3 Levels in Patients With Esophageal Squamous Cell Cancer | en_US |
| dc.type | Article | en_US |